
The tool used to alter the expression of the parasite is called morpholino oligomer (MO), used to block access to of other molecules to certain RNA sequences. The Yale research team believes this can disrupt the parasites development in red blood cells. "The ease in design of the MO molecules presents a possibility for their use in large-scale genome functional analyses and possibly in malaria therapy." This could ultimately lead to a quick and inexpensive solution to malaria across the globe, all through the use of preventative genetics.
The article can be found here.
No comments:
Post a Comment